Preventable deaths involving medicines in England and Wales, 2013-22: a systematic case series of coroners’ reports

Author:

France Harrison SORCID,Aronson Jeffrey KORCID,Heneghan CarlORCID,Ferner Robin EORCID,Cox Anthony RORCID,Richards Georgia CORCID

Abstract

AbstractObjectivesTo identify medicines-related deaths in coroners’ reports and to explore concerns to prevent future deaths.DesignRetrospective case series of coroners’ Prevention of Future Deaths reports (PFDs).SettingEngland and Wales.ParticipantsIndividuals identified in 3897 PFDs dated between 1 July 2013 and 23 February 2022, collected from the UK’s Courts and Tribunals Judiciary website using web scraping, and populated into an openly available database:https://preventabledeathstracker.net/Main outcome measuresProportion of PFDs in which coroners reported that a therapeutic medicine or drug of abuse caused or contributed to a death; characteristics of the included PFDs; coroners’ concerns; recipients of PFDs and the timeliness of their responses.Results704 PFDs (18%; 716 deaths) involved medicines, representing an estimated 19,740 years of life lost (average of 50 years lost per death). Opioids (22%), antidepressants (9.7%), and hypnotics (9.2%) were the most common drugs involved. Coroners expressed 1249 concerns, primarily related to patient safety (29%) and communication (26%), including failures of monitoring (10%) and poor communication between organisations (7.5%). NHS England (6%), the Department of Health and Social Care (5%) and the Medicines and Healthcare products Regulatory Agency (2%) received the most medicines-related PFDs. However, most expected responses to PFDs (51%; 615/1245) were not reported on the UK’s Courts and Tribunals Judiciary website.ConclusionsOne in five deaths deemed preventable by coroners involved medicines. Taking actions to address coroners’ concerns, including improving patient safety and poor communication, should increase the safety of medicines. Many concerns were raised repeatedly, but half of PFD recipients failed to respond, suggesting that lessons are not generally learned. The rich information in PFDs should be used to foster a learning environment in clinical practice that may help reduce preventable deaths.Trial registrationhttps://doi.org/10.17605/OSF.IO/TX3CSSummary boxWhat is already known on this topic?Medicines are essential to the provision of healthcare, but if used inappropriately, have the potential to cause significant harms, including death. When an unnatural death occurs, these deaths are often reported to the coroner, which can result in a report to highlight concerns to prevent future deaths. Samples of coroners’ reports have been analysed to identify concerns relating to preventable deaths involving medicines, which found that anticoagulants contributed the most. However, an investigation of all available reports has not been conducted to determine the overall impact of medicines.What this study adds?One in five preventable deaths in England and Wales involved a medicine or drug of misuse, costing nearly 20,000 years of life lost. Opioids, antidepressants, and hypnotics were the most common medicines involved in preventable deaths. Coroners repeatedly raised similar concerns, primarily relating to patient safety and communication. However, it is unclear whether these reports are being used in clinical practice to guide actions to prevent similar deaths.

Publisher

Cold Spring Harbor Laboratory

Reference43 articles.

1. Taylor S , Annand F , Burkinshaw P , Greaves F , Kelleher M , Knight J , et al. Dependence and withdrawal associated with some prescribed medicines: an evidence review. London; 2019 Sep.

2. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model;Age Ageing [Internet],2018

3. How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000–2013;Int Health [Internet],2019

4. Drug-related deaths in hospital inpatients: A retrospective cohort study;Br J Clin Pharmacol [Internet],2018

5. Drug-related mortality among inpatients: a retrospective observational study;Eur J Clin Pharmacol [Internet],2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3